Impaired in vitro erythropoiesis following deletion of the scl (Tal1) +40 enhancer is largely compensated for in Vivo despite a significant reduction in expression

Rita Ferreira, Dominik Spensberger, Yvonne Silber, Andrew Dimond, Juan Li, Anthony R. Green*, Berthold Göttgens

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impaired in vitro erythropoiesis following deletion of the scl (Tal1) +40 enhancer is largely compensated for in Vivo despite a significant reduction in expression'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry